In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.

MLA

Todo, T., et al. “In Situ Expression of Soluble B7-1 in the Context of Oncolytic Herpes Simplex Virus Induces Potent Antitumor Immunity.” Cancer Research, vol. 61, no. 1, Jan. 2001, pp. 153–61. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=11196154&authtype=sso&custid=ns315887.

APA

Todo, T., Martuza, R. L., Dallman, M. J., & Rabkin, S. D. (2001). In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity. Cancer Research, 61(1), 153–161.

Chicago

Todo, T, R L Martuza, M J Dallman, and S D Rabkin. 2001. “In Situ Expression of Soluble B7-1 in the Context of Oncolytic Herpes Simplex Virus Induces Potent Antitumor Immunity.” Cancer Research 61 (1): 153–61. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=11196154&authtype=sso&custid=ns315887.